Strides Shasun gains on plan to merge wholly owned subsidiaries with itself

01 Nov 2017 Evaluate

Strides Shasun is currently trading at Rs. 830.00, up by 2.75 points or 0.33% from its previous closing of Rs. 827.25 on the BSE.

The scrip opened at Rs. 820.05 and has touched a high and low of Rs. 840.75 and Rs. 820.05 respectively. So far 27423 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 802.55 on 31-Oct-2017.

Last one week high and low of the scrip stood at Rs. 861.35 and Rs. 802.55 respectively. The current market cap of the company is Rs. 7468.19 crore.

The promoters holding in the company stood at 31.12%, while institutions and non-institutions held 50.12% and 18.76% respectively.

Strides Shasun has received an approval for the Scheme of Amalgamation for the merger of its wholly owned subsidiaries (WOSs) viz., Arrow Remedies, Fagris Medica and Strides Chemicals, with itself. The Board of Directors of the company at their meeting held on October 31, 2017, considered and approved the same.

The merger is expected to generate synergic benefits, greater efficiency in business management, reduce duplication of statutory and regulatory compliances and eliminate duplication of operating and administrative expenses.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×